Key result
Nine pathogenic CLCNKB mutations causing Bartter syndrome lead to decreased ClC-Kb currents through altered channel trafficking, reduced membrane insertion, or functional inactivation at the membrane.
Why the study?
Pathological missense mutations in CLCNKB cause a wide spectrum of clinical phenotypes in Bartter syndrome type III, and molecular analysis can help classify mutations by functional alteration.
Pathogenic CLCNKB mutations causing Bartter syndrome type III lead to decreased ClC-Kb currents through diverse mechanisms including altered trafficking, reduced membrane insertion, and functional inactivation at the membrane surface.
May inform targeted therapies for Bartter syndrome type III; extends mechanistic insights but remains hypothesis-generating in animal models.
Pathological missense mutations in CLCNKB gene give a wide spectrum of clinical phenotypes in Bartter syndrome type III patients. Molecular analysis of the mutated ClC-Kb channels can be helpful to classify the mutations according to their functional alteration. We investigated the functional consequences of nine mutations in the CLCNKB gene causing Bartter syndrome. We first established that all tested mutations lead to decreased ClC-Kb currents. Combining electrophysiological and biochemical methods in Xenopus laevis oocytes and in MDCKII cells, we identified three classes of mutations. One class is characterized by altered channel trafficking. p.A210V, p.P216L, p.G424R, and p.G437R are totally or partially retained in the endoplasmic reticulum. p.S218N is characterized by reduced channel insertion at the plasma membrane and altered pH-sensitivity; thus, it falls in the second class of mutations. Finally, we found a novel class of functionally inactivated mutants normally present at the plasma membrane. Indeed, we found that p.A204T alters the pH-sensitivity, p.A254V abolishes the calcium-sensitivity. p.G219C and p.G465R are probably partially inactive at the plasma membrane. In conclusion, most pathogenic mutants accumulate partly or totally in intracellular compartments, but some mutants are normally present at the membrane surface and simultaneously show a large range of altered channel gating properties.
No takes yet. Share an insight, caveat, or question.
Bignon et al. (2019) studied Bartter syndrome type III. CLCNKB mutations vs. Wild-type was evaluated on Functional consequences (channel trafficking, pH-sensitivity, calcium-sensitivity, channel gating properties). Nine pathogenic CLCNKB mutations causing Bartter syndrome lead to decreased ClC-Kb currents through altered channel trafficking, reduced membrane insertion, or functional inactivation at the membrane.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: